Nuvectis Pharma, Inc. NVCT Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Nuvectis Pharma, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvectis Pharma, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvectis Pharma, Inc.'s cash ratio?
- Nuvectis Pharma, Inc. (NVCT) reported cash ratio of 2.2× in Q1 2026.
- How has Nuvectis Pharma, Inc.'s cash ratio changed year-over-year?
- Nuvectis Pharma, Inc.'s cash ratio decreased by 30.8% year-over-year, from 3.2× to 2.2×.
- What is the long-term trend for Nuvectis Pharma, Inc.'s cash ratio?
- Over 4 years (2021 to 2025), Nuvectis Pharma, Inc.'s cash ratio has grown at a 0.1% compound annual growth rate (CAGR), from 2.4× to 2.4×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.